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Background—Light to moderate alcohol consumption is associated with a reduced risk of coronary heart disease. This
protective effect of alcohol, however, may be confined to middle-aged or older individuals. Coronary heart disease
incidence is low in men 40 years of age and in women 50 years of age; for this reason, study cohorts rarely have
the power to investigate the effects of alcohol on coronary heart disease risk in younger adults. This study examined
whether the beneficial effect of alcohol on coronary heart disease depends on age.
Methods and Results—In this pooled analysis of 8 prospective studies from North America and Europe including 192 067
women and 74 919 men free of cardiovascular diseases, diabetes, and cancers at baseline, average daily alcohol intake
was assessed at baseline with a food frequency or diet history questionnaire. An inverse association between alcohol and
risk of coronary heart disease was observed in all age groups; hazard ratios among moderately drinking men (5.0 to 29.9
g/d) 39 to 50, 50 to 59, and 60 years of age were 0.58 (95% confidence interval [CI], 0.36 to 0.93), 0.72 (95% CI,
0.60 to 0.86), and 0.85 (95% CI, 0.75 to 0.97) compared with abstainers. However, the analyses indicated a smaller
incidence rate difference between abstainers and moderate consumers in younger adults (incidence rate difference, 45
per 100 000; 90% CI, 8 to 84) than in middle-aged (incidence rate difference, 64 per 100 000; 90% CI, 24 to 102) and
older (incidence rate difference, 89 per 100 000; 90% CI, 44 to 140) adults. Similar results were observed in women.
Conclusion—Alcohol is also associated with a decreased risk of coronary heart disease in younger adults; however, the
absolute risk was small compared with middle-aged and older adults. (Circulation. 2010;121:1589-1597.)
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The association between alcohol intake and coronaryheart disease (CHD) has been thoroughly investigated
over the past decades with regard to both the amount and
type consumed.1– 4 In recent years, the importance of
drinking pattern has also been considered.5–7 In general,
alcohol intake is consistently linked with a lower risk of
CHD. Age-specific incidence rates of CHD vary consid-
erably, being very low in men 40 years of age and in
women 50 years of age.8 For this reason, the statistical
power to investigate the effects of alcohol on CHD in
younger adults is limited. Most results are obtained from
cohorts consisting of middle-aged and older adults, and
only a few studies have addressed the effects of alcohol on
CHD in younger adults.9,10 In principle, the cause of CHD
among younger adults may differ from that among older
individuals; for instance, relatively more cases of CHD
among younger adults may be attributable to genetic
causes.11,12 Hence, alcohol may not necessarily protect
against CHD in this age group. We pooled data from 8
studies to increase sample size and to enable the investi-
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gation of associations between alcohol intake and CHD in
subsets of populations defined by age group.
Clinical Perspective on p 1597
Methods
Study Population
The analyses were based on data from the Pooling Project of Diet
and Coronary Disease. The inclusion criteria were the following: a
prospective study with at least 150 incident coronary cases, assess-
ment of usual dietary intake, and a validation study of the diet
assessment method. The following 12 studies met these criteria and
agreed to share data: Adventists Health Study (AHS),13 Atheroscle-
rosis Risk in Communities Study (ARIC),14 -Tocopherol,
-Carotene Cancer Prevention Study (ATBC),15 Finnish Mobile
Clinic Health Examination (FMC),16 Glostrup Population Study
(GPS),17 Health Professionals Follow-Up Study (HPFS),18 Israeli
Ischemic Heart Disease Study (IIHD),19 Iowa Women’s Health
Study (IWHS),20 Nurses’ Health Study (NHS),21 Va¨sterbotten Inter-
vention Program (VIP),22 and Women’s Health Study (WHS).23 The
AHS included only nondrinkers, and the FMC and IIHD studies were
excluded from the present analysis because of missing information
on alcohol intake. In addition, IWHS was excluded from main
analyses because of self-reported information on CHD. The 8
remaining studies are presented in Table 1. The NHS was divided
into 2 segments, thereby taking advantage of repeated assessments
on dietary intake and the long follow-up period. The 2 segments are
referred to as NHSa (1980 to 1986) and NHSb (1986 to 1996). The
second segment comprised only women who remained free of CHD
after the first follow-up period, and cases were included in whichever
segment they occurred.
Measurements
Average daily alcohol intake was assessed at baseline with a food
frequency or diet history questionnaire inquiring about typical intake
of alcoholic beverages. For each beverage, grams of daily alcohol
intake were calculated from information on the amount and fre-
quency of consumption and the alcohol content of the beverage.
Study-specific conversion factors for the alcohol content were used.
A standard drink contains 10 to 15 g pure alcohol. Total alcohol
intake was given by the sum of the beverage-specific intakes.
The outcome of interest was incident CHD events (both fatal and
nonfatal). All 8 included studies used validated methods to define
nonfatal and fatal CHD cases.24
Statistical Methods
Participants were excluded if they reported energy intakes beyond 3 SD
from the study-specific, log-transformed mean energy intake of the
baseline population (1% of the study population). Persons35 years of
age or with a history of cardiovascular disease, diabetes, or cancers
(other than nonmelanoma skin cancer) were also excluded. Participants
were followed up from baseline to date of CHD event, date of death, or
end of follow-up, whichever occurred first. Follow-up periods 10
years (ARIC and GPS) were truncated to reduce heterogeneity. Individ-
ual studies were combined through the use of an aggregated pooled
analysis technique allowing for calculation of a single exposure-effect
estimate while adjusting for study origin.25
The hazard ratios of CHD were ascertained by the Cox
proportional-hazards regression model with age as underlying time
Table 1. Baseline Characteristics of Included Studies
Study and
Sex
Baseline
Cohort*
Year of
Questionnaire
Mean Age (90%
Limit), y
Follow-Up,
Person-y
CHD Cases, n Alcohol Intake
CHD
Deaths
Total CHD
Events
Median† (5th–95th
Percentile), g/d
Abstainers,
%
ARIC
Male 5217 1987–1989 54.6 (45–64) 45 652 51 267 12.1 (1.9–56.6) 45.8
Female 6462 1987–1989 53.9 (45–64) 58 019 18 122 6.8 (1.5–30.2) 69.8
ATBC
Male 21 141 1984–1988 57.3 (50–69) 121 813 534 1339 13.7 (0.8–62.3) 10.2
GPS
Male 1658 1974–1995 51.9 (35–80) 14 365 79 102 20.8 (2.7–72.6) 6.2
Female 1666 1974–1995 51.5 (35–80) 14 605 34 34 8.9 (1.3–35.1) 18.0
HPFS
Male 41 754 1986–1988 53.4 (39–77) 383 206 421 1273 9.7 (1.0–46.1) 23.0
NHSa
Female 81 415 1980–1982 47.1 (35–66) 513 915 97 397 5.6 (0.8–35.0) 31.4
NHSb
Female 61 706 1986–1988 52.6 (39–66) 607 049 208 696 4.9 (0.9–35.9) 34.2
VIP
Male 9521 1992–1996 49.1 (39–70) 39 230 38 134 4.4 (0.2–15.8) 4.7
Female 10 555 1992–1996 49.3 (39–70) 43 872 4 23 1.7 (0.1–7.3) 11.4
WHS
Female 37 272 1992–1995 53.9 (38–89) 190 755 10 152 3.7 (0.9–28.4) 40.0
Total
Male 79 291 1974–1996 54.0 (35–80) 604 266 1123 3115 9.6 (0.9–50.4) 18.5
Female 199 076 1974–1996 50.4 (35–89) 1 428 216 371 1424 4.7 (0.8–35.0) 33.9
*Sample size after exclusion of participants with baseline cardiovascular diseases, cancers, diabetes mellitus, and missing information on alcohol intake.
†Median values were calculated for drinkers only.
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scale, allowing for delayed entry (left censoring).26 Absolute risks
(incidence rates) describing the scale of CHD according to sex, age,
and level of alcohol intake were estimated by means of Poisson
regression.27 Absolute risk differences were calculated, and 90%
confidence limits were derived by bootstrap estimation (5000 repli-
cations) with the 5th and 95th percentiles of the distribution as the
lower and upper limits.
We performed primary analyses considering the risk of CHD in
categories of alcohol consumption (0, 0.1 to 4.9, 5.0 to 14.9, 15.0 to
29.9, 30.0 to 59.9, and60.0 g/d in women; 0, 0.1 to 4.9, 5.0 to 14.9,
15.0 to 29.9, 30.0 to 59.9, 60.0 to 89.9, and 90.0 g/d in men) both
for each individual study and for the pooled cohort. The study
population was analyzed separately in the following 3 age groups: 39
to 49.9, 50 to 59.9, and 60 years. Age was updated during
follow-up, and participants were assigned to the appropriate age
category; thus, each person could contribute person-time at risk to
1 age category.
Additional analyses exploring the risk of CHD per alcohol
increment (1 g/d) were performed. Alcohol was modeled continu-
ously using second-degree fractional polynomials, thus allowing for
a single turning point (the nadir) in the risk function. Following the
results of Corrao and others,1 a model describing the dose-response
relationship of alcohol on CHD including both a linear and root-
squared term of alcohol was applied.
The P value for the test for trend was obtained by assigning the
median value within categories of alcohol intake and using this
variable as a continuous variable. SAS statistical package version 9.1
was used for all analyses.28
We harmonized the variables of the different studies, and the
following set of potential confounders was identified on the basis of
the method of causal diagrams as suggested by Greenland and
others29: educational level (less than high school, high school, more
than high school), smoking (never smokers, ex-smokers, and current
smokers of 1 to 4, 5 to 14, 15 to 24, or 25 cigarettes per day), body
mass index (BMI; 18.5, 18.5 to 24.9, 25.0 to 29.9, and 30
kg/m2), total energy intake (kcal/d), and energy-adjusted quintiles of
cholesterol, dietary fiber, saturated fat, monounsaturated fat, and
polyunsaturated fat intake. Physical activity measures varied across
the cohorts, measured either according to an energy expenditure
score of weekly time spent on various activities during the past year
(ARIC, HPFS, NHS, VIP, and WHS) or according to the intensity of
the average weekly physical activity during the past 12 months
(ATBC, GPS). These measures were harmonized to a 5-level
variable from 1 (least active) to 5 (most active).30–32 In addition,
models were stratified by study origin and baseline year to account
for differences in follow-up procedures or questionnaire design and
period effects. Information on postmenopausal hormone therapy use
was unavailable in VIP; therefore, the main analyses for women did
not include adjustment for this factor. Sensitivity analyses included
measures of self-reported history of physician-diagnosed elevated
cholesterol (dyslipidemia) and hypertension (yes/no).
Results
Baseline Characteristics
Baseline characteristics of participants from the 8 included
studies are shown in Table 1. In total, the pooled study
population comprised 199 076 women and 79 291 men who
experienced 1424 and 3115 coronary events during 1 428 216
and 604 266 person-years of follow-up, respectively. Base-
line age of participants varied from 35 to 89 years in women
and from 35 to 80 years in men with a mean age of 50.4 and
54.0 years, respectively. The proportion of nondrinkers varied
substantially between studies from 11.4% to 53.0% in women
and from 4.7% to 45.8% in men. Median alcohol intakes
varied from 4.4 to 20.8 g/d in men and from 1.7 to 8.9 g/d in
women.
Tables 2 and 3 show characteristics of participants in-
cluded in the pooled cohort according to alcohol consump-
tion. Heavier alcohol intake was associated with higher
proportions of smokers, physical inactivity, and hypertension
and lower median intakes of fat and fiber; a moderate alcohol
intake was associated with the highest median cholesterol
intake compared with abstainers and heavy drinkers. In men,
Table 2. Baseline Characteristics of Women in the Pooled Cohort According to Daily Alcohol Intake
Total Nondrinkers
Alcohol Intake, g/d
0.1–4.9 5.0–14.9 15.0–29.9 30.0–59.9 60.0
n* 192 067 65 121 67 187 39 177 12 258 7418 906
CHD events, n 1365 596 390 241 65 58 15
Age, mean (SD), y 50.4 (7.6) 51.0 (7.7) 49.8 (7.7) 50.1 (7.5) 50.5 (7.4) 51.1 (7.3) 51.3 (7.2)
Education, low, n (%)† 8276 (4) 2186 (3) 4719 (7) 936 (2) 322 (3) 96 (1) 17 (2)
Smokers, n (%) 44 513 (23) 11 971 (18) 14 547 (22) 10 454 (27) 3628 (30) 3426 (46) 487 (54)
BMI, mean (SD), kg/m2 25.0 (10.1) 26.0 (5.3) 25.1 (4.5) 24.0 (3.8) 23.7 (3.6) 23.9 (3.8) 24.4 (4.2)
Physical inactivity, n (%) 66 248 (25) 24 382 (37) 21 858 (33) 12 760 (33) 3859 (31) 2971 (40) 418 (46)
Diet, median (5th–95th
percentile)
Polyunsaturated fat,‡ g/d 5.4 (3.3–8.4) 5.5 (3.4–8.6) 5.4 (3.4–8.4) 5.4 (3.4–8.4) 5.3 (3.2–8.3) 4.8 (2.8–7.9) 4.0 (2.2–6.9)
Monounsaturated fat,‡ g/d 13.1 (8.1–20.5) 13.1 (7.9–20.7) 13.0 (8.3–20.5) 13.2 (8.4–20.5) 12.9 (8.2–19.7) 12.3 (7.7–19.0) 10.6 (6.4–16.8)
Saturated fat,‡ g/d 12.8 (7.7–20.0) 12.7 (7.5–20.1) 13.0 (8.0–20.2) 12.9 (7.9–20.1) 12.6 (7.6–19.7) 11.9 (7.2–18.6) 10.3 (5.7–16.8)
Fiber,‡ g/d 15.4 (8.4–25.7) 15.7 (8.5–26.7) 15.9 (8.9–26.1) 15.0 (8.3–24.4) 14.2 (7.8–23.1) 12.2 (6.7–20.4) 10.3 (5.0–18.9)
Cholesterol,‡ mg/d 254 (139–458) 252 (134–464) 249 (137–451) 264 (148–460) 263 (151–464) 252 (143–443) 222 (121–394)
Total energy, kcal/d 1603 (900–2627) 1579 (871–2637) 1581 (893–2589) 1614 (915–2608) 1678 (977–2689) 1758 (1070–2749) 2008 (1283–3050)
Hypertension, n (%) 35 637 (19) 13 566 (21) 11 695 (17) 6271 (16) 2137 (17) 1695 (23) 273 (30)
Dyslipidemia, n 20 850 (11) 8389 (13) 6599 (10) 3787 (10) 1217 (10) 731 (10) 127 (14)
Differences in distribution of covariates across levels of alcohol consumption were tested by ANOVA (age, BMI), Kruskal-Wallis (dietary factors), and 2 tests
(education, smoking, physical activity, hypertension, and dyslipidemia). All tests showed statistically significant differences (P0.0001).
*After exclusion of participants with missing information on any of the relevant covariates.
†Defined as less than high school.
‡Energy adjusted.
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a higher frequency low educational level was observed
among participants in the highest alcohol group. Similar
distributions of covariates according to alcohol intake were
observed across cohorts.
Alcohol Consumption and Risk of CHD
Tables 4 and 5 show the relative risks (hazard ratios) of
CHD by categories of alcohol intake for each of the studies
and pooled estimates for women and men. In women, an
inverse relation between alcohol intake and CHD was
found in each individual study except for VIP. The
confidence bounds around risk estimates for this particular
study were very broad because the reference category
included only 2 cases. In men, an inverse relation was
observed in all studies. In the pooled analysis, we observed
a significantly lower risk of CHD among women with an
Table 3. Baseline Characteristics of Men in the Pooled Cohort According to Daily Alcohol Intake
Total Nondrinkers
Alcohol Intake, g/d
0.1–4.9 5.0–14.9 15.0–29.9 30.0–59.9 60.0–89.9 90.0
n* 74 720 13 904 19 030 20 556 11 375 7789 1546 520 (1)
CHD events, n 2961 623 737 751 449 311 59 31
Age, mean (SD), y 54.0 (8.4) 54.4 (8.6) 53.3 (8.7) 53.6 (8.5) 54.6 (7.6) 55.2 (7.6) 55.2 (7.6) 55.8 (6.2)
Education, low, n (%)† 20 773 (28) 2513 (18) 6125 (32) 5580 (27) 3590 (32) 2283 (29) 450 (29) 232 (45)
Smokers, n (%) 28 144 (38) 3338 (24) 6086 (32) 7409 (36) 5688 (50) 4254 (55) 952 (62) 417 (80)
BMI, mean (SD),
kg/m2
25.8 (8.2) 26.0 (3.8) 25.8 (3.4) 25.7 (3.4) 25.8 (3.4) 25.9 (3.5) 26.1 (3.9) 26.5 (4.1)
Physical inactivity,
n (%)
18 850 (25) 3740 (27) 4411 (23) 4489 (22) 2956 (26) 2421 (31) 572 (37) 261 (80)
Diet, median
(5th–95th
percentile)
Polyunsaturated
fat,‡ g/d
5.4 (3.3–8.9) 5.5 (3.3–9.0) 5.3 (3.4–8.8) 5.4 (3.4–8.9) 5.4 (3.2–9.0) 5.2 (3.0–8.8) 4.6 (2.6–8.2) 4.1 (2.2–7.8)
Monounsaturated
fat,‡ g/d
12.8 (8.5–16.8) 12.9 (8.0–17.3) 12.8 (8.6–16.8) 12.9 (8.8–16.8) 12.9 (9.0–16.6) 12.4 (8.3–16.3) 11.3 (7.4–15.4) 10.5 (6.8–15.5)
Saturated fat,‡ g/d 13.2 (7.5–23.8) 12.3 (6.9–22.8) 13.6 (7.7–24.0) 13.3 (7.7–24.0) 13.9 (7.8–24.5) 13.2 (7.4–23.5) 12.7 (6.5–21.6) 13.3 (6.5–21.0)
Fiber,‡ g/d 19.8 (11.5–32.3) 20.7 (11.6–35.7) 21.0 (12.7–33.5) 20.1 (12.3–31.8) 19.1 (11.5–30.1) 17.0 (10.1–27.4) 14.6 (8.3–24.5) 12.9 (6.6–21.2)
Cholesterol,‡ mg/d 322 (174–573) 315 (161–568) 303 (166–536) 322 (177–566) 349 (193–602) 343 (190–610) 323 (176–606) 324 (167–544)
Total energy, kcal/d 2135 (1149–3671) 1929 (1044–3438) 2047 (1120–3537) 2111 (1173–3598) 2311 (1274–3823) 2387 (1344–3911) 2652 (1518–4138) 3054 (1570–4662)
Hypertension, n (%) 14 388 (19) 2759 (20) 3292 (17) 3634 (18) 2246 (20) 1902 (24) 421 (27) 134 (26)
Dyslipidemia,§ n 5076 (9) 1145 (10) 1114 (8) 1312 (9) 720 (11) 609 (13) 147 (17) 29 (16)
Differences in distribution of covariates across levels of alcohol consumption were tested by ANOVA (age, BMI), Kruskal-Wallis (dietary factors), and 2 tests
(education, smoking, physical activity, hypertension, and dyslipidemia). All tests showed statistically significant differences (P0.0001).
*After exclusion of participants with missing information on any of the relevant covariates.
†Defined as less than high school.
‡Energy-adjusted.
§This information was not available for ATBC.
Table 4. Study-Specific and Pooled Hazard Ratios of CHD for Categories of Daily Alcohol Intake for Women
n
Hazard Ratio,
Nondrinkers
(CHD606)
Hazard Ratio (95% CI) by Daily Alcohol Intake, g/d
P for
Trend
0.1–4.9
(CHD397)
5.0–14.9
(CHD242)
15.0–29.9
(CHD65)
30.0–59.9
(CHD60)
60.0
(CHD15)
Study specific
ARIC 6406 1.00 (Reference) 0.84 (0.44–1.59) 0.58 (0.29–1.17) 0.78 (0.30–2.00) NA§ NA§ 0.0738
GPS 1509 1.00 (Reference) 0.75 (0.27–2.06) 0.89 (0.31–2.55) 1.15 (0.31–4.23) 0.52 (0.05–5.21) NA§ 0.8418
NHSa 79 479 1.00 (Reference) 0.73 (0.57–0.94) 0.72 (0.55–0.95) 0.59 (0.38–0.94) 0.49 (0.29–0.82) 1.64 (0.77–3.49) 0.1548
NHSb 60 083 1.00 (Reference) 0.78 (0.65–0.94) 0.67 (0.54–0.84) 0.47 (0.32–0.69) 0.57 (0.39–0.82) 0.60 (0.26–1.38) 0.0003
VIP 9758 1.00 (Reference) 2.26 (0.28–18.47) 2.17 (0.12–38.67) NA§ NA§ NA§ 0.8654
WHS 34 832 1.00 (Reference) 1.02 (0.69–1.50) 0.81 (0.49–1.35) 0.37 (0.11–1.19) 0.58 (0.18–1.90) 1.32 (0.18–9.95) 0.1768
Pooled
Age adjusted* 192 067 1.00 (Reference) 0.78 (0.69–0.89) 0.73 (0.62–0.84) 0.57 (0.44–0.74) 0.80 (0.61–1.05) 1.71 (1.02–2.86) 0.1112
Smoking adjusted† 192 067 1.00 (Reference) 0.75 (0.65–0.85) 0.62 (0.53–0.72) 0.47 (0.36–0.61) 0.52 (0.39–0.68) 1.02 (0.61–1.70) 0.0001
Multivariable‡ 192 067 1.00 (Reference) 0.78 (0.69–0.90) 0.68 (0.59–0.80) 0.52 (0.40–0.67) 0.53 (0.39–0.70) 0.93 (0.55–1.58) 0.0001
*Also adjusted for year of baseline questionnaire.
†Also adjusted for age and year of baseline questionnaire.
‡Multivariable hazard ratios were adjusted for age, year of baseline questionnaire, smoking, BMI, education, physical activity, energy intake, polyunsaturated fat,
monounsaturated fat, saturated fat, fiber, cholesterol intake, and study origin.
§Not applicable because of a limited number of cases.
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alcohol intake of up to 60 g/d and among men with an
alcohol intake of up to 90 g/d.
We also performed analyses describing the risk of CHD
according to alcohol consumption modeled as a continuous
variable (Figure 1). In both men and women, a reduction in
CHD risk was observed at low to moderate levels of alcohol.
The relative risk of CHD was 0.58 (95% confidence interval
[CI], 0.49 to 0.68) in women and 0.69 (95% CI, 0.62 to 0.76)
in men with a daily intake of 30 g/d, corresponding to 2 to
3 drinks. Higher levels of alcohol consumption were not
associated with any discernible additional protection in
women and with only modest protection in men.
Alcohol Consumption and Risk of CHD in
Age Strata
We estimated the risks of CHD according to alcohol intake
separately for 3 age groups (50, 50 to 59, and 60 years;
Figure 2). In all age groups and for both men and women, a
decreased risk of CHD according to alcohol intake was
observed but with broader confidence bounds for the young-
est age group. The test for interaction between alcohol and
age was not statistically significant in either women (P0.34)
or men (P0.25). We also modeled the risk continuously for
the different age groups and observed similar shapes of the
curves (data not shown).
Incidence rates of CHD in women and men according to
alcohol intake and age are displayed in Figure 3. As expected,
the incidence of CHD was much lower in the younger
compared with older participants. The incidence rates of
CHD among female abstainers in the 3 age groups were 11
(95% CI, 1 to 109), 41 (95% CI, 1 to 400), and 103 (95% CI,
9 to 1018) per 100 000, respectively. In male abstainers, the
incidence rates were 114 (95% CI, 77 to 171), 262 (95% CI,
201 to 343), and 454 (95% CI, 354 to 553) per 100 000 for the
3 age groups, respectively. In all age groups and in both men
and women, the incidence rate was lower among participants
with a low to moderate alcohol intake compared with abstain-
ers. In women, the incidence rate differences between drink-
ing 0 g/d and 5.0 to 29.9 g/d were 3 (90% CI, 1 to 25), 16
(90% CI, 0 to 111), and 35 (90% CI, 0 to 250). For men, the
corresponding incidence rate differences were 45 (90% CI, 8
to 84), 64 (90% CI, 24 to 102), and 89 (90% CI, 44 to 140)
per 100 000.
Sensitivity Analyses
Heterogeneity between study-specific effects was assessed by
the inclusion of an interaction term between alcohol and
study origin under the null hypothesis of no between-study
differences in the relative risk of CHD by alcohol intake,1,25
with no sign of heterogeneity detected (P0.95 in women,
P0.12 in men). In addition, comparing pooled risk estimates
Table 5. Study–Specific and Pooled Hazard Ratios of CHD for Categories of Daily Alcohol Intake for Men
n
Hazard Ratio,
Nondrinkers
(CHD623)
Alcohol Intake, g/d
P for
Trend
0.1–4.9
(CHD737)
5.0–14.9
(CHD751)
15.0–29.9
(CHD449)
30.0–59.9
(CHD311)
60.0–89.9
(CHD59)
90.0
(CHD31)
Study specific
ARIC 5166 1.00 (Reference) 1.16 (0.78–1.71) 1.29 (0.93–1.79) 0.87 (0.57–1.32) 0.73 (0.44–1.22) 0.74 (0.27–2.04) 1.40 (0.56–3.54) 0.4499
ATBC 21 119 1.00 (Reference) 0.86 (0.71–1.03) 0.86 (0.72–1.03) 0.70 (0.58–0.85) 0.61 (0.49–0.77) 0.48 (0.32–0.74) 0.80 (0.51–1.27) 0.0001
GPS 1294 1.00 (Reference) 0.84 (0.30–2.32) 0.54 (0.21–1.38) 0.60 (0.24–1.50) 0.44 (0.16–1.18) 0.37 (0.09–1.52) NA§ 0.0304
HPFS 38 654 1.00 (Reference) 1.00 (0.85–1.17) 0.75 (0.63–0.88) 0.69 (0.56–0.86) 0.66 (0.52–0.83) 0.65 (0.41–1.01) 0.17 (0.02–1.23) 0.0001
VIP 8486 1.00 (Reference) 0.50 (0.28–0.93) 0.24 (0.11–0.48) 0.25 (0.07–0.91) 0.73 (0.09–5.85) NA§ NA§ 0.009
Pooled
Age-adjusted* 74 719 1.00 (Reference) 0.95 (0.85–1.06) 0.84 (0.75–0.93) 0.75 (0.66–0.85) 0.74 (0.64–0.85) 0.70 (0.53–0.91) 0.96 (0.67–1.39) 0.0001
Smoking-adjusted† 74 719 1.00 (Reference) 0.94 (0.84–1.05) 0.81 (0.72–0.90) 0.71 (0.63–0.81) 0.66 (0.58–0.76) 0.60 (0.46–0.79) 0.81 (0.57–1.18) 0.0001
Multivariable‡ 74 719 1.00 (Reference) 0.96 (0.86–1.08) 0.83 (0.74–0.92) 0.72 (0.64–0.82) 0.66 (0.57–0.76) 0.58 (0.44–0.77) 0.77 (0.53–1.13) 0.0001
*Also adjusted for year of baseline questionnaire.
†Also adjusted for age and year of baseline questionnaire.
‡Multivariable hazard ratios were adjusted for age, year of baseline questionnaire, smoking, BMI, education, physical activity, energy intake, polyunsaturated fat,
monounsaturated fat, saturated fat, fiber, cholesterol intake, and study origin.
§Not applicable because of a limited number of cases.
Figure 1. Relative risk functions (95%
CI) describing the dose-response rela-
tion between alcohol intake and risk of
CHD. Analyses were adjusted for year of
baseline questionnaire, education, smok-
ing, BMI, physical activity, total energy
intake, polyunsaturated fat, monounsatu-
rated fat, saturated fat, fiber, and choles-
terol intake. The fitted model (SE) is
reported. The 99th percentile of cases
was 64 g/d in women and 90 g/d in
men. The highest alcohol intake in
observed cases was 90 g/d in women
and 215 g/d in men.
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after systematically excluding each study at a time confirmed
that no single study strongly influenced the pooled esti-
mates.33 Hence, the pooled hazard ratios are considered
appropriate summaries of the study-specific data. Performing
a test for interaction between age (time scale) and alcohol
consumption did not yield violations of the proportional-
hazards assumption for either women (P0.10) or men
(P0.22).
Separate analyses were performed for fatal and nonfatal
events to examine whether the effect of alcohol on CHD
differed according to the severity of the outcome. The results
of this analysis did not reveal obvious differences between
the 2 measures of outcome, although a tendency toward an
elevated risk of fatal CHD was observed for the highest
alcohol category in both women and men (data not shown).
To examine the possibility that latent baseline symptoms of
CHD might reduce the alcohol intake, thereby biasing the
results, we performed analyses in which the first 2 or 4 years
after baseline were excluded. This did not attenuate the
estimates (data not shown).
Additional analyses for women were performed to examine
whether adjustment for postmenopausal hormone replace-
ment therapy had an impact on results. This involved exclud-
ing participants with unavailable information on this partic-
ular covariate (n9799, 5% of the study population). In the
remaining cohorts, postmenopausal hormone replacement
therapy did not appreciably affect the association between
alcohol and risk of CHD. In addition, the inclusion of history
of hypertension and dyslipidemia as covariates in the model
did not affect the risk estimates of CHD according to alcohol
consumption. Furthermore, an analysis was performed in-
cluding the IWHS (n29 801). This inclusion also did not
change the hazard ratios appreciably (data not shown).
A test for interaction between alcohol and smoking was
performed to examine whether the estimates of the effect
of alcohol on CHD risk differed according to smoking
status. Smoking did not modify the association between
alcohol and CHD in either men (P0.79) or women
(P0.14). Additional analyses including nonsmokers only
were performed separately for women (n100 144) and
Figure 2. Sex- and age-specific pooled
hazard ratios of CHD for categories of
daily alcohol intake. Multivariable hazard
ratios were adjusted for year of baseline
questionnaire, education, smoking, BMI,
physical activity, total energy intake,
polyunsaturated fat, monounsaturated
fat, saturated fat, fiber, and cholesterol
intake. n indicates number cases for
each sex and age group.
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men (n46 576) for alcohol levels of 0, 0.1 to 14.9, 15.0
to 29.9, and 30.0 g/d and showed similar associations
(data not shown).
Discussion
In this pooled cohort of 8 prospective studies, we observed a
lower risk of CHD among men and women with a light to
moderate alcohol intake compared with nondrinkers. This
finding was consistent across different age groups without
significant variations in dose response.
The current data on the effect of alcohol on CHD in
younger adults are sparse. In a study based on the Honolulu
Heart Program, the authors compared CHD risk according to
conventional risk factors in middle-aged and older men (age,
45 to 93 years). Compared with nondrinkers, they observed a
lower risk of CHD among drinkers in middle-aged but not
among older participants (75 years) and concluded accord-
ingly that the relation between alcohol and CHD weakened
with age. The study, however, was limited by the simple
categorization of alcohol intake into drinkers or nondrinkers
and included men only.10
Several plausible explanations for the lowered risk of CHD
among moderate drinkers exist. Among those explanations,
the evidence is probably strongest for a mechanism involving
alcohol increasing high-density lipoprotein cholesterol and
reducing plasma fibrinogen levels, thereby reducing platelet
aggregability.7,34 The hypothesized J-shaped relation between
alcohol intake and diabetes mellitus could also explain some
of the benefit from alcohol intake.35,36 In addition, alcohol has
an effect on plasminogen activator inhibitor-1 that would tend
to reduce thrombosis.37
Previous studies have suggested that the causes of CHD in
younger adults differ from the mechanisms involved with
CHD in older persons. Results from the Honolulu Heart
Program indicated that the effect of hypertension, BMI, and
cholesterol on CHD differed according to age. For instance,
the relative risk of CHD in hypertensive men declined from
3.7 in those 45 to 54 years of age to 1.7 in those 75 years
of age. Similarly, associations between BMI and total cho-
lesterol weakened with advancing age.10 The Coronary Artery
Risk in Young Adults (CARDIA) study of men and women
33 to 45 years of age found that alcohol intake was associated
with expected dose response between alcohol and high-
density lipoprotein cholesterol levels and an inverse relation
between alcohol and fibrinogen levels.9 They also observed
an increased risk of coronary calcification with greater
alcohol consumption. Because coronary calcification is a
marker of atherosclerosis, this result in young adults is not
consistent with the results of the present study.9
Another aspect of alcohol consumption related to age is
drinking patterns. Younger adults may tend to binge drink
more often than older persons, which may increase their risk
of CHD5,7,9; however, findings from the CARDIA study did
not indicate a protective effect of alcohol intake on coronary
calcification in younger adults even after the exclusion of
binge drinkers.9
Our findings suggest a J-shaped curve in women, but in
men, the risk did not increase significantly at high amounts of
alcohol. Biomarkers that mediate the association between
alcohol and decreased risk of CHD such as high-density
lipoprotein and fibrinogen are found to explain a larger
proportion of the association among men than among women,
which may indicate that alcohol has specific effects on such
mediators according to sex.7 Other biological explanations for
sex-specific associations include differences in alcohol phar-
macokinetics (ie, processing and elimination of alcohol in the
body), which depend largely on body composition.38,39 How-
ever, because the risk curves of this study were modeled
separately for the 2 sexes, comparisons between them are not
straightforward.
The present study is one of only a few existing studies
focusing on the effects of alcohol on CHD according to age.
Our work was based on a large body of data with thorough
measurements of alcohol intake and relevant covariates. A
strength was the availability of diet data in the Pooling
Project of Diet and Coronary Disease that enabled adjustment
for potential dietary confounders. The size of the study
population allowed us to perform subset analyses exploring
the association between alcohol and CHD in strata of younger
men and women, aspects that even large individual cohorts do
not have the power to address. The findings of the present
study were strengthened by the prospective design, which
provided information on the sequence of events allowing for
conclusions on causality, assuming proper confounding con-
trol. Potential confounders of the association between alcohol
and CHD were carefully selected on the basis of directed
Figure 3. Incidence rates of CHD according to age and alcohol
intake. Analyses were adjusted for year of baseline question-
naire, education, smoking, BMI, physical activity, total energy
intake, polyunsaturated fat, monounsaturated fat, saturated fat,
fiber, and cholesterol intake.
Hvidtfeldt et al Alcohol and CHD in Age Strata 1595
 by guest on January 15, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
acyclic graphs, ensuring a minimally sufficient set of covari-
ates. Furthermore, the inclusion criteria of the Pooling Project
of Diet and Coronary Disease enabled adjustment for relevant
dietary factors, which most previous studies did not control
for. The pooled analyses included both cohorts and interven-
tion studies from North America and Europe, and similar
effects were observed across the studies. Finally, an advan-
tage of the Pooling Project is the inclusion of previously
unpublished results, thereby reducing the risk of publication
bias.
However, several limitations of the study should also be
considered. We focused on the importance of the amount of
alcohol consumed; however, other aspects of patterns of
alcohol intake may be equally important and were not
addressed. Our study included only information on current
alcohol consumption and confounders at baseline. For this
reason, the reference category of abstainers may contain
former drinkers who quit because of existing illness, which
could cause a moderate alcohol intake to appear more
protective than it is. Although several studies that included
only lifelong or long-term abstainers in this category have
confirmed a protective effect of alcohol even among healthy
individuals,6,40 the “sick-quitter” hypothesis is relevant in the
present context because older age groups may include more
abstainers who stopped drinking because of illness (eg,
hypertension).
As mentioned, patterns of alcohol consumption (eg, choice
of alcohol type and frequency of consumption) may differ
considerably with age, which we did not account for. Our
findings of protective effects of alcohol on CHD in all
examined age groups may indicate that neither the type of
alcohol nor the frequency of consumption modifies the
influence of alcohol on CHD considerably. However, future
research based on observational studies should emphasize
other measures of alcohol intake such as frequency of alcohol
consumed. Furthermore, cohort studies with information on
lifetime alcohol intake or repeated measurements of alcohol
intake and potential confounders could contribute valuable
insight because changes in alcohol intake over a given period
may be of great importance. Additional experimental studies
are also needed to expand the knowledge of biological
mechanisms.
Furthermore, this study focused only on CHD events.
Overall effects of alcohol on all-cause morbidity and mortal-
ity must be considered if we are to optimize alcohol guide-
lines for different age groups of the population. The lower
risk of all-cause mortality is expected to be caused mainly by
the effects of alcohol on CHD. In this study, a lower risk of
CHD was observed in all examined age groups in moderate
alcohol consumers compared with abstainers; however, the
absolute risk of CHD was rather low in the youngest age
group. Thus, considering the increasing contribution of CHD
to all-cause mortality with age, it is reasonable to assume that
the protective effect of alcohol on all-cause mortality is
mostly pronounced in older age groups. This issue has been
addressed in a few previous studies indicating that the
protective effect of alcohol consumption on mortality in
general is confined to middle-aged and older individu-
als.4,41,42 Unfortunately, information on all-cause mortality
was not collected in the database of the Pooling Project of
Diet and Coronary Disease.
Conclusions
This study supports current knowledge that alcohol in mod-
erate amounts protects against CHD in both men and women.
Our findings further suggest that this effect is also present in
younger age groups. However, younger adults are at low risk
for CHD, and the beneficial effects obtained by a moderate
alcohol intake may be negligible compared with the increased
risk of, for instance, traffic accidents and cancer. Recommen-
dations on alcohol intake among younger adults should
consider all-cause mortality and morbidity.
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CLINICAL PERSPECTIVE
The association between alcohol consumption and decreased risk of coronary heart disease is well established, but possible
age differences are plausible because of potential pathogenic differences in coronary heart disease events occurring in
younger compared with middle-aged or older individuals. We studied these relations in a large population of men and
women 35 to 89 years of age at baseline. We observed a lower risk of coronary heart disease among men and women with
a light to moderate alcohol intake compared with nondrinkers, and this finding was consistent and of similar size in all age
groups. However, the absolute risk of CHD was small in the youngest age group, and risk differences between abstainers
and light to moderate alcohol consumers were of negligible size. Therefore, our results provide strong evidence for a lower
risk of coronary heart disease among moderate consumers relative to nondrinkers in younger, middle-aged, and older
adults; however, considering absolute risks across age groups, younger adults are not likely to benefit from an overall
recommendation of moderate alcohol intake.
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